Hospital News and Research

RSS

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.

31 Aug 2009

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.

31 Aug 2009

First Edition: August 31, 2009

Today's headlines hint that summer's almost over, but the heat will still be on for health reform.

31 Aug 2009

Abbott introduces XIENCE PRIME Everolimus Eluting Coronary Stent System for global market

Abbott (NYSE: ABT) today announced at the European Society of Cardiology Congress the widespread availability of its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

31 Aug 2009

New trial data shows that BIOTRONIK monitoring system is safe and effective for detecting patients' clinical events

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced that new data from the TRUST (Lumos-T Safely Reduces Routine Office Device Follow Up) trial presented at the European Society of Cardiology Congress 2009 demonstrate the benefits of BIOTRONIK Home Monitoring in the early detection of patient clinical events as well as the safe reduction of in-office follow-up visits.

31 Aug 2009

Spinal implant developed by Sanfor Clinic neurosurgeon receives FDA market clearance

Sanford Health, a comprehensive health care provider in the Upper Midwest, announced today a spinal implant developed by Sanford Clinic Neurosurgeon, Wilson Asfora, MD, Sanford Clinic Neurosurgery & Spine, has received United States Food and Drug Administration (FDA) 510(k) market clearance as a lumbar intervertebral body fusion device.

31 Aug 2009

Findings reveal that Americans have grown increasingly confident to pay for healthcare services

A new report -- Thomson Reuters Healthcare Indexes(TM): Consumer Confidence -- found that consumer confidence related to healthcare expenditures increased 12 percent between March and July.

31 Aug 2009

Axolotl's annual customer conference to examine current and emerging industry opportunities

Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and related services, will be holding its annual customer conference themed —“It's About Illumination” September 9-11, 2009 at the Mandalay Bay, Las Vegas, Nevada.

31 Aug 2009

Results of the Phase II SEPIA-ACS1/ TIMI-42 study presented at the plenary session of the Annual European Society of Cardiology

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.

31 Aug 2009

New radiotherapy treatment devised for treating women with metastatic ovarian cancer

In the future, women with metastatic ovarian cancer could be treated with a radioactive substance that can seek and destroy tumour cells. An initial study in patients conducted jointly by the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital has found that the treatment has no unwanted side-effects.

31 Aug 2009

Boston Scientific appoints Senior Vice President for its Cardiac Rhythm Management group

Boston Scientific Corporation (NYSE: BSX) today announced that Ken Stein, M.D., FACC, will join the Company as Senior Vice President and Associate Chief Medical Officer for its Cardiac Rhythm Management (CRM) group. Dr. Stein is currently the Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at Cornell University.

31 Aug 2009

Study reveals that downregulation of IRF-8 gene causes gum diseases, arthritis and osteoporosis

Investigators at Hospital for Special Surgery, collaborating with researchers from other institutions, have contributed to the discovery that a gene called interferon regulator factor-8 (IRF-8) is involved in the development of diseases such as periodontitis (gum disease), rheumatoid arthritis and osteoporosis. The study, which will be published online August 30, ahead of print, in the journal Nature Medicine, could lead to new treatments in the future.

31 Aug 2009

RE-LY trial establishes effectiveness of PRADAX in reducing stroke risk in AF patients

Results of the landmark RE-LY(R) Trial (Randomized Evaluation of Long term anticoagulant therapy) demonstrate that atrial fibrillation (AF) patients taking PRADAX(R) (dabigatran etexilate) 150mg twice daily (BID) significantly reduced their risk of stroke and systemic embolism by 34 per cent (p less than 0.001) as compared to patients well-controlled on warfarin, without increasing the risk of major bleeding.

31 Aug 2009

Intermediate dosages of otamixaban reduce acute coronary complications

30 Aug 2009

Clinical data of the REVERSE trial reveals how CRT improves functioning of the heart

Cardiac resynchronization therapy (CRT) is a proven therapy indicated for patients with moderate to severe heart failure. Additional 24-month clinical data presented today on the European cohort of 262 patients in the REVERSE (Resynchronization Reverse Remodeling in Systolic Left Ventricular Dysfunction) trial, sponsored by Medtronic, Inc., provides a deeper understanding of how CRT improves the function of the heart, including reduction in heart size and improvements in pumping efficiency, in certain heart failure patients with mild symptoms.

30 Aug 2009

Scientists explore the fundamental basis of the lateral-line sensory system

Fish and some amphibians possess a unique sensory capability in the so-called lateral-line system. It allows them, in effect, to "touch" objects in their surroundings without direct physical contact or to "see" in the dark. Professor Leo van Hermmen and his team in the physics department of the Technische Universitaet Muenchen are exploring the fundamental basis for this sensory system. What they discover might one day, through biomimetic engineering, better equip robots to orient themselves in their environments.

29 Aug 2009

Leading experts in health and health care reform to take part in symposium

With the nation facing a $9 trillion deficit over the next 10 years, according to government estimates, the future of health care reform depends upon a neglected but critical leg of the equation: cost. Some of the nation’s leading experts in health and health care reform will provide insights into this issue when they converge in Nashville Saturday for a nonpartisan public discussion.

29 Aug 2009

BioAlliance Pharma to discuss nanoparticle technology and its therapeutic applications at the French-Norwegian Interdisciplinary Symposium

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that it will present its nanoparticle technology and the latter's advantages in therapeutic applications at the French-Norwegian Interdisciplinary Symposium on Nano and Micro Frontiers in Biology and Medicine, to take place in Bergen, Norway, from August 31 to September 2, 2009.

29 Aug 2009

New contract agreement reached between Stanford Hospital & Clinics, Packard Children’s hospital and the SEIU-UHW union

Lucile Packard Children’s Hospital and Stanford Hospital & Clinics announce that the hospitals have reached a new contract agreement with employees represented by the SEIU United Healthcare Workers West (SEIU-UHW) union. The SEIU-UHW membership, which represents 1,450 out of 9,172 employees at the hospitals in jobs such as housekeeping, food service, nursing assistants, and technicians, ratified the contract in a vote Thursday, August 27.

29 Aug 2009

Science and technology tours to be conducted in conjunction with the G20 Pittsburgh Summit

The University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center will be hosting 12 science and technology tours Sept. 21 in conjunction with the G20 Pittsburgh Summit Sept. 24-25. These tours of cutting-edge research and development will help explain how and why the "eds and meds" sector of Pittsburgh's economy has become a powerful driver of the region's success.

29 Aug 2009

Hospital News and Research

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

First Edition: August 31, 2009

Abbott introduces XIENCE PRIME Everolimus Eluting Coronary Stent System for global market

New trial data shows that BIOTRONIK monitoring system is safe and effective for detecting patients' clinical events

Spinal implant developed by Sanfor Clinic neurosurgeon receives FDA market clearance

Findings reveal that Americans have grown increasingly confident to pay for healthcare services

Axolotl's annual customer conference to examine current and emerging industry opportunities

Results of the Phase II SEPIA-ACS1/ TIMI-42 study presented at the plenary session of the Annual European Society of Cardiology

New radiotherapy treatment devised for treating women with metastatic ovarian cancer

Boston Scientific appoints Senior Vice President for its Cardiac Rhythm Management group

Study reveals that downregulation of IRF-8 gene causes gum diseases, arthritis and osteoporosis

RE-LY trial establishes effectiveness of PRADAX in reducing stroke risk in AF patients

Intermediate dosages of otamixaban reduce acute coronary complications

Clinical data of the REVERSE trial reveals how CRT improves functioning of the heart

Scientists explore the fundamental basis of the lateral-line sensory system

Leading experts in health and health care reform to take part in symposium

BioAlliance Pharma to discuss nanoparticle technology and its therapeutic applications at the French-Norwegian Interdisciplinary Symposium

New contract agreement reached between Stanford Hospital & Clinics, Packard Children’s hospital and the SEIU-UHW union

Science and technology tours to be conducted in conjunction with the G20 Pittsburgh Summit

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News